Skip to main content
    E

    Edesa Biotech Inc (EDSA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.82
    +0.04 (+1.44%)

    Market Cap: $37.56M

    Last updated: Oct 20, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(21/37)
    Avg Surprise
    -110.16%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.84
    Range$-0.84 - $-0.83
    3 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-N/A---
    Sep 26EST
    		-$-0.84---
    Jun 26
    Reported Aug 13
    		$-0.60$-0.44-36.36%Miss-140.0%
    Mar 26
    Reported May 14
    		$-0.49$-0.26-88.46%Miss-63.3%
    Dec 25
    Reported Feb 13
    		$-0.28$-0.45+37.78%Beat+41.7%
    Sep 25
    Reported Dec 12
    		$-0.32$-0.56+42.86%Beat-10.3%
    Jun 25
    Reported Aug 8
    		$-0.25$-0.26+3.85%Beat+51.9%
    Mar 25
    Reported May 14
    		$-0.30$-0.29-3.45%Miss+48.3%
    Dec 24
    Reported Feb 14
    		$-0.48$-0.31-54.84%Miss+11.1%
    Sep 24
    Reported Dec 13
    		$-0.29$-0.54+46.30%Beat+51.7%
    Jun 24
    Reported Aug 9
    		$-0.52$-0.58+10.34%Beat+25.7%
    Mar 24
    Reported May 10
    		$-0.58$-0.69+15.94%Beat+31.0%
    Dec 23
    Reported Feb 9
    		$-0.54N/A+55.37%Beat+40.7%
    Sep 23
    Reported Dec 15
    		$-0.60$-0.71+15.49%Beat-2900.0%
    Jun 23
    Reported Aug 9
    		$-0.70$-1.21+42.15%Beat+73.0%
    Mar 23
    Reported May 11
    		$-0.84$-1.21+30.58%Beat+63.6%
    Dec 22
    Reported Feb 10
    		$-0.91$-1.33+31.58%Beat-175.8%
    Sep 22
    Reported Dec 16
    		$-0.02N/A+94.87%Beat+99.3%
    Jun 22
    Reported Aug 12
    		$-2.59$-3.01+13.95%Beat+19.1%
    Mar 22
    Reported May 13
    		$-2.31$-2.57+10.12%Beat+59.3%
    Dec 21
    Reported Feb 14
    		$-0.33$-0.40+17.50%Beat+81.9%
    Sep 21
    Reported Dec 28
    		$-2.86$-2.94+2.72%Beat-1200.0%
    Jun 21
    Reported Aug 13
    		$-3.20$-0.98-226.53%Miss-128.6%
    Mar 21
    Reported May 14
    		$-5.67$-2.73-107.69%Miss-376.5%
    Dec 20
    Reported Feb 16
    		$-1.82$-1.54-18.18%Miss-1113.3%
    Sep 20
    Reported Dec 7
    		$-0.22$-0.20-10.00%Miss+60.0%
    Jun 20
    Reported Aug 12
    		$-1.40$-1.61+13.04%Beat-366.7%
    Mar 20
    Reported May 15
    		$-1.19$-1.82+34.62%Beat+36.0%
    Dec 19
    Reported Feb 13
    		$-0.15N/AN/ABeat+90.4%
    Sep 19
    Reported Dec 12
    		$-0.55N/A+68.39%Beat-129.2%
    Jun 19
    Reported Aug 14
    		$-0.30N/A+81.48%Beat+88.9%
    Mar 19
    Reported May 8
    		$-1.86$-1.56-19.23%Miss-106.7%
    Dec 18
    Reported Feb 5
    		$-1.56$-0.23-578.26%Miss-67.7%
    Sep 18
    Reported Nov 30
    		$-0.24$-0.24+0.00%Beat+70.4%
    Jun 18
    Reported Aug 8
    		$-2.70$-0.10-2600.00%Miss-221.4%
    Mar 18
    Reported May 8
    		$-0.90$-0.09-900.00%Miss-16.9%
    Dec 17
    Reported Feb 5
    		$-0.93$-0.70-32.86%Miss+11.4%
    Sep 17
    Reported Dec 1
    		$-0.81$0.00N/ABeat-
    Jun 17
    Reported Aug 9
    		$-0.84$-0.77-9.09%Miss-
    Mar 17
    Reported May 9
    		$-0.77$-0.70-10.00%Miss-
    Dec 16
    Reported Feb 6
    		$-1.05$-0.70-50.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio-1.67EV/EBITDAN/A
    Price/FCF-2.84xFCF Yield-35.24%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-122.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.76xQuick Ratio2.76x
    Trading Statistics
    Beta1.22Avg Volume43.41K
    52-Week High$20.3252-Week Low$0.72

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.03
    SMA 20$3.46
    SMA 50$4.22
    SMA 200$5.61
    EMA 10$3.00
    EMA 20$3.36
    EMA 50$4.17
    EMA 200$5.06

    MACD

    Line: -0.45Signal: -0.40Hist: -0.05

    ADX

    ADX: 25.8+DI: 15.4-DI: 29.0

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down92.0
    PSAR$3.55

    Bollinger Bands

    Upper Band$4.59
    Lower Band$2.33
    %B Position6519%(Upper)
    Band Width0.21

    RSI (14-Day)

    Neutral
    32.7

    Momentum Oscillators

    Stoch %K11.8
    Stoch %D8.1
    Williams %R-82.4
    ROC (10d)-24.2%
    Momentum-0.90
    CCI (20d)-84.9
    MFI (14d)28.9

    Volatility Measures

    ATR (14d)$0.33(11.8%)
    StdDev (20d)0.56
    Hist Vol110.5%(High)

    Volume Flow

    VWAP$2.88
    OBV205.8M
    AD Line95.7M
    CMF (20d)-0.434

    Volume Metrics

    Avg Vol (20d)44.3K
    Vol Ratio0.8x
    VWMA (20d)$3.34

    Pivot Points

    R3$3.29
    R2$3.10
    R1$2.94
    Pivot Point$2.76
    S1$2.59
    S2$2.41
    S3$2.25

    Advanced Oscillators

    TSI-37.25
    Ultimate Osc25.2
    KST-275.49

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$50,918$0$0$0$0$0$0$0$0$0$-1,118,100
    Cost of Revenue$25,644$25,872$25,459$25,868$25,787$24,509$43,109$44,206$51,415$45,397$45,031$45,970
    Gross Profit$-25,644$-25,872$-25,459$-25,868$-25,787$-24,509$-43,109$-44,206$-51,415$-45,397$-45,031$-45,970
    Operating Expenses$5.52M$4.27M$2.32M$2.44M$1.90M$1.64M$1.90M$960,190$1.93M$2.22M$1.81M$2.32M
    R&D$3.96M$2.77M$1.12M$1.23M$939,067$484,306$1.02M$103,867$897,305$1.18M$704,458$953,399
    SG&A$1.56M$1.53M$1.22M$1.24M$964,676$1.15M$878,871$900,529$1.04M$1.04M$1.15M$1.42M
    Operating Income$-5,519,549$-4,296,994$-2,341,383$-2,470,248$-1,903,743$-1,638,886$-1,898,689$-1,004,396$-1,932,445$-2,220,474$-1,857,430$-2,369,663
    Interest Income$275$639$47$55$572$265$1,666$16,491$32,848$43,193$60,966$71,945
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$120,520
    Income Before Tax$-5,407,611$-4,217,532$-2,247,669$-2,228,358$-1,749,464$-1,589,648$-1,617,253$-962,051$-1,668,212$-1,860,531$-1,678,451$-1,720,343
    Income Tax Expense$0$800$0$0$0$800$0$0$4$800$-1$122,791
    Net Income$-5,407,611$-4,218,332$-2,247,669$-2,228,358$-1,749,464$-1,590,448$-1,617,253$-962,051$-1,668,212$-1,861,331$-1,678,451$-1,720,343
    EBITDA$-5,493,905$-4,271,122$-2,315,923$-2,197,230$-1,694,675$-1,562,109$-1,554,385$-960,190$-1,644,804$-1,871,075$-1,691,564$-2,323,693
    EBIT$-5,519,549$-4,296,994$-2,341,383$-2,223,098$-1,720,462$-1,586,618$-1,597,494$-1,004,396$-1,696,219$-1,916,472$-1,736,595$-2,369,663
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about EDSA

    News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

    This article details the performance of twelve health care stocks during Tuesday's after-market trading session. Six companies experienced gains, including XORTX Therapeutics and Edesa Biotech, while another six...

    Benzinga•10/20/26•Somewhat-Bullish

    Edesa Biotech Clears IND for Phase 2 EB06 Study in Vitiligo

    Edesa Biotech has received FDA clearance for its Investigational New Drug (IND) application for a Phase 2 study of EB06 in vitiligo...

    The Clinical Trial Vanguard•10/16/26•Bullish

    Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study

    Edesa Biotech has received FDA Investigational New Drug (IND) clearance for its Phase 2 study of EB01, a sPLA2 inhibitor...

    Moomoo•10/15/26•Bullish

    Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study

    Edesa Biotech announced that the FDA has cleared its Investigational New Drug (IND) application for a Phase 2 clinical study of EB06 in vitiligo...

    GlobeNewswire•10/15/26•Bullish

    Edesa Biotech receives FDA clearance for vitiligo study expansion By Investing.com

    Edesa Biotech (NASDAQ:EDSA) has received FDA clearance for its Investigational New Drug application to expand its Phase 2 clinical study of EB06 for vitiligo into the United States. This will allow the clinical-stage...

    Investing.com Canada•10/15/26•Bullish

    EDSA Valuation and Fair Value

    P/E
    -1.7x
    Forward P/E
    0.2x
    P/FCF
    -2.8x
    P/B
    2.9x
    See GNG's fair value

    EDSA Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -122.9%
    FCF margin
    -1790437.8%
    FCF yield
    -35.2%

    EDSA Competitors

    CompanyTicker
    Precipio IncPRPO
    CryoCell International IncCCEL
    Rapid Micro Biosystems IncRPID
    eXoZymes, Inc.EXOZ
    Veru IncVERU
    Harvard Bioscience IncHBIO
    FibroGen IncFGEN
    Star Equity Holdings IncSTRR

    Sector: Healthcare

    EDSA Bull Case vs Bear Case

    Bear case

    • EDSA's quarterly revenue changed -99.9% year over year.

    EDSA Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -6.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.84

    Frequently Asked Questions About EDSA

    Does EDSA pay dividends?

    Edesa Biotech Inc (EDSA) does not currently pay a regular dividend.

    What is EDSA's market cap?

    Edesa Biotech Inc (EDSA) has a market capitalization of $37.56M with a current stock price of $2.82.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In